A Polytherapy Strategy Using Vincristine and ALK Inhibitors to Sensitise EML4-ALK-Positive NSCLC

SIMPLE SUMMARY: Lung cancer is the third most common cancer worldwide with poor survival after initial diagnosis. A large proportion, approximately 85%, of patients with lung cancer are classified as non-small cell lung cancer (NSCLC). The most common genetic alterations in NSCLCs are KRAS, EGFR and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sampson, Josephina, Ju, Hyun-min, Song, Ji-young, Fry, Andrew M., Bayliss, Richard, Choi, Jene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833940/
https://www.ncbi.nlm.nih.gov/pubmed/35159046
http://dx.doi.org/10.3390/cancers14030779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833940/
https://www.ncbi.nlm.nih.gov/pubmed/35159046
http://dx.doi.org/10.3390/cancers14030779

Ejemplares similares